Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-18 15:31:07 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-2600(25)00240-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260025002401
其他信息:
出版社: Elsevier BV
作者: Tetsuhiko Asao; Yu Saida; Satoshi Watanabe; Akira Kisohara; Kazuma Kishi; Ryo Morita; Taku Nakagawa; Yoko Tsukita; Naoki Furuya; Taichi Miyawaki; Nobuhisa Ishikawa; Tadaaki Yamada; Takahiro Tanaka; Satoshi Morita; Toshiaki Kikuchi; Makoto Maemondo; Kunihiko Kobayashi; Takashi Kasai; Takaaki Sasaki; Ken Masubuchi; Ryo Koyama; Kosuke Ichikawa; Hiroshi Watanabe; Seiji Niho; Toshihiko Hino; Jun Sugisaka
